Coherence Neuro is developing technology that uses electrical biomarkers to continuously monitor cancer and potentially enable adaptive treatment systems. The company aims to create a platform of "read/write" devices that can monitor and treat cancer in real-time, moving towards chronic human trials in glioblastoma and expanding its preclinical pipeline. This funding will advance their technology towards FDA Breakthrough Device designation and further clinical programs.

Total raised
Undisclosed
tracked to date
Latest round
Series A
Oct 23, 2026
Known investors
9
led by Founders Fund
Press coverage
4
outlets tracked

Is this your company?

Claim this profile to get matched with investors who fund Health startups in United States.

Claim this profile →

🏆 Featured in Datapile’s Q4 2026 USA Funding Report

Read the Q4 2026 USA report →
Add this badge to your site
<a href="https://datapile.co/reports/q4-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q4 2026 USA Funding Report</a>

Funding history

  1. 1
    $45 MillionSeries AOct 23, 2026

    Led by Founders Fund

    Announcement ↗

Founder

Elise Jenkins
Elise Jenkins

Investors in Coherence Neuro

Backers from this company's tracked funding rounds.

  • FFounders FundLead investorVC firm
  • TThe OpenAI Startup FundVC firm
  • LLux CapitalVC firm
  • 88VCVC firm
  • TTimelessVC firm
  • OOlive CapitalVC firm
  • AAhrenVC firm
  • DDr. Matthew MacDougallAngel
  • OOpenAI Startup FundVC firm

Coherence Neuro in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile